Threshold of HbA1c for the Effect of Hyperalycemia on the Risk of Diabetic Microangiopathy

Danne, Thomas; Weber, Bruno; Dinesen, Bo; Mortensen, Henrik B

doi:10.2337/diacare.19.2.183

Article navigation

Letters| February 01 1996

Threshold of HbA_1c for the Effect of Hyperalycemia on the Risk of Diabetic Microangiopathy

Thomas Danne, MD;

Thomas Danne, MD

Children's Hospital, University of Glostrup, Kaiserin Auguste Victoria Haus, Virchow-Klinikum, Hum boldt University

Berlin, Germany

Search for other works by this author on:

This Site

PubMed

Google Scholar

Bruno Weber, MD, FRCP;

Bruno Weber, MD, FRCP

Children's Hospital, University of Glostrup, Kaiserin Auguste Victoria Haus, Virchow-Klinikum, Hum boldt University

Berlin, Germany

Search for other works by this author on:

This Site

PubMed

Google Scholar

Bo Dinesen, MSC;

Bo Dinesen, MSC

Steno Diabetes Center

,

Gentofte

Search for other works by this author on:

This Site

PubMed

Google Scholar

Henrik B Mortensen, MD

Department of Pediatrics, University of Glostrup

Glostrup, Denmark

Search for other works by this author on:

This Site

PubMed

Google Scholar

Address correspondence to Thomas Panne, MD, Kinderklinik, Virchow-Klinikum, Med. Fakultat dor Humboldt Universität Berlin, Augustenburger Platz, 13353 Berlin, Germany

Diabetes Care 1996;19(2):183

https://doi.org/10.2337/diacare.19.2.183

PubMed:

8718448

Threshold of HbA_1c for the Effect of Hyperalycemia on the Risk of Diabetic Microangiopathy

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Threshold of HbA1c for the Effect of Hyperalycemia on the Risk of Diabetic Microangiopathy

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only

Threshold of HbA_1c for the Effect of Hyperalycemia on the Risk of Diabetic Microangiopathy